Eric Raymond

Scientific Advisor
Pharmaceutical Sciences
PharmaEngine Taiwan
Taiwan

Business Expert Toxicology
Biography

Prof. Raymond joined the Scientific Advisory Board of PharmaEngine in January 2017. He is the Head of Medical Oncology at Paris Saint-Joseph Hospital Group and Professor of Medical Oncology at Denis Diderot Paris 7 University & consultant in medical oncology at Bichat Hospital. He was the Principal Investigator of > 50 clinical trials, including phase I, II, and III studies. Some of his works were seminal in the development of phase III trials and registration of some drugs such as oxaliplatin, sunitinib, temsirolimus and everolimus. He received his M.D. and Ph.D. from Pierre et Marie Curie Paris 6 University, France.

Research Intrest

Oncology